Ectopic pituitary adenoma in the sphenoid causing Nelson's syndrome

1997 ◽  
Vol 111 (6) ◽  
pp. 565-567 ◽  
Author(s):  
Francisco Esteban ◽  
Isabel Ruiz-Avila ◽  
Ricardo Vilchez ◽  
Carolina Gamero ◽  
Mercedes Gomez ◽  
...  

AbstractAn ectopic functioning pituitary in the sphenoid is an extremely rare occurrence, and even rarer is pituitary adenoma causing symptoms of Nelson's syndrome. A case is presented of a young female diagnosed and treated in our clinic. The only functioning hypophyseal tissue was detected inside the sphenoid, as the pituitary gland had been radiated because of Cushing's syndrome 10 years before and imaging studies revealed an empty sella.

1980 ◽  
Vol 93 (3) ◽  
pp. 351-355 ◽  
Author(s):  
Anna A. Kasperlik-Zaluska ◽  
Wojciech Jeske

Abstract. Serum prolactin (Prl) levels in basal conditions and those following metoclopramide administration (10 mg orally) were determined in 10 women with Cushing's syndrome, 9 patients bilaterally adrenalectomized for adrenal hyperplasia without clinical evidence of a pituitary tumour, and one after adrenal adenoma removal, 8 women with Nelson's syndrome and 12 normal subjects. Blood samples were taken at 1 and 2 h after metoclopramide administration. In patients with hyperadrenocorticism the Prl responsiveness was reduced compared into the bilaterally adrenalectomized patients and the control group. In the bilaterally adrenalectomized patients without features of a pituitary adenoma, Prl responses to metoclopramide were significantly higher than those in the remaining subjects under investigation. In the patients with Nelson's syndrome mean baseline Prl was higher than that in the other groups studied; serum Prl responses to metoclopramide were significantly lower than those in the bilaterally adrenalectomized patients with no evidence of a pituitary tumour. These results indicate that: 1) hypercortisolaemia of Cushing's disease diminishes Prl responses to metoclopramide, 2) the elimination of hypercortisolaemia by adrenalectomy results in a hyperresponsiveness of serum Prl to metoclopramide, 3) the development of Nelson's tumours is associated with increased baseline Prl and with significantly lower Prl responses to metoclopramide compared with those found in the other patients adrenalectomized for Cushing's syndrome, without clinical evidence of a pituitary adenoma.


1987 ◽  
Vol 115 (3) ◽  
pp. 419-422 ◽  
Author(s):  
Linda Bardram ◽  
Jörgen Lindholm ◽  
Jens F. Rehfeld

Abstract. Twelve of 87 pituitary adenomas from patients with acromegaly, Cushing's syndrome, Nelson's syndrome, hyperprolactinaemia and without symptoms of hormone hypersecretion contained gastrin in concentrations from 0.5 to 166 pmol/g. Only ACTH-producing tumours contained gastrin, which occurred in forms smaller than those present in the normal adenohypophysis. The results indicate that corticotropic tumours may synthesize gastrin in moderate amounts.


2006 ◽  
Vol 186 (5) ◽  
pp. 1468-1469 ◽  
Author(s):  
Chandan Jyoti Das ◽  
Ashu Seith ◽  
Shivanand Gamanagatti ◽  
Ravinder Goswami

1987 ◽  
Vol 96 (6) ◽  
pp. 569-572
Author(s):  
Paul A. Levine ◽  
Cameron A. Gillespie ◽  
Jeffrey S. Walker ◽  
Warner M. Burch ◽  
Patrick D. Kenan ◽  
...  

2011 ◽  
Vol 23 (1) ◽  
pp. 135-136 ◽  
Author(s):  
Yoshikazu Kusano ◽  
Tetsuyoshi Horiuchi ◽  
Fusakazu Oya ◽  
Yoshinari Miyaoka ◽  
Kazuhiro Oguchi ◽  
...  

1976 ◽  
Vol 65 (3) ◽  
pp. 337-343 ◽  
Author(s):  
Kalman Kovacs ◽  
Eva Horvath ◽  
Norbert A. Kerenyi ◽  
Robert H. Sheppard

2007 ◽  
Vol 106 (6) ◽  
pp. 988-993 ◽  
Author(s):  
William J. Mauermann ◽  
Jason P. Sheehan ◽  
Daniel R. Chernavvsky ◽  
Edward R. Laws ◽  
Ladislau Steiner ◽  
...  

Object Patients with adrenocorticotropic hormone (ACTH)–secreting pituitary adenomas may require a bilateral adrenalectomy to treat their Cushing's disease. Approximately one third of these patients, however, will experience progressive enlargement of the residual pituitary adenoma, develop hyperpigmentation, and have an elevated level of serum ACTH. These patients with Nelson's syndrome can be treated with Gamma Knife surgery (GKS). Methods The prospectively collected University of Virginia Gamma Knife database of patients with pituitary adenomas was reviewed to identify all individuals with Nelson's syndrome who were treated with GKS. Twenty-three patients with a minimum of 6 months of follow up were identified in the database. These patients were assessed for tumor control (that is, lack of tumor growth over time) with neuroimaging studies (median follow-up duration 22 months) and for biochemical normalization of their ACTH levels (median follow-up duration 50 months). Neuroimaging follow-up studies were available for 22 patients, and endocrine follow up was available for 15 patients in whom elevation of ACTH levels was documented prior to GKS. In the 22 patients in whom neuroimaging follow-up studies were available, 12 had a decrease in tumor size, eight had no tumor growth, and two had an increase in tumor volume. Ten of 15 patients with elevated ACTH levels prior to GKS showed a decrease in their ACTH levels at last follow up; three of these 10 patients achieved normal ACTH levels (< 50 pg/ml) and the other five patients with initially elevated values had an increase in ACTH levels. Ten patients were thoroughly evaluated for post-GKS pituitary function; four were found to have new pituitary hormone deficiency and six did not have hypopituitarism after GKS. One patient suffered a permanent third cranial nerve palsy and four patients are now deceased. Conclusions Gamma Knife surgery may control the residual pituitary adenoma and decrease ACTH levels in patients with Nelson's syndrome. Delayed hypopituitarism or cranial nerve palsies can occur after GKS. Patients with Nelson's syndrome require continued multidisciplinary follow-up care. Given the difficulties associated with management of Nelson's syndrome, even the modest results of GKS may be helpful for a number of patients.


Sign in / Sign up

Export Citation Format

Share Document